Abogen Biosciences Showcases AI-Driven mRNA Platform and RNA Innovations at UK-SEA Vax Hub Meeting 2025 Ahead of IPO

Dr. Ying Bo, Founder, Chairman and CEO of Abogen, has been invited to attendUK-SEA Vax Hub Meeting 2025And delivered a keynote speech.

At that time, he will share the latest explorations and practices in the full-process automation and intelligent construction of mRNA vaccines, demonstrating how to accelerate and enhance vaccine research and development through technological innovation, providing new ideas for the sustainable development of global vaccine manufacturing capabilities.

This year's annual meeting brought together scholars from renowned universities in the UK, experts and industry leaders in the field of vaccine research and production in Southeast Asia, coveringFrontier Technology Sharing, In-depth Academic Discussion, and Expansion of Investment Cooperation Opportunities, aiming to showcase the technical strength and phased achievements within the region, and to promote the coordinated development of scientific research and the industrial community.

The annual meeting is also expected to help Malaysia achieve its strategic goal of vaccine self-sufficiency and accelerate the cultivation of a new generation of vaccine scientists and biomedical engineers.

Abogen Sharing Session

1. Dr. Abogen's Speech

Time:June 19, 2025 10:10 – 10:55 a.m.

Subject:An AI-Driven and Fully Automated mRNA Vaccine Platform

2. Poster Presentation

  
ABO1105, A Novel Lyophilized RSV mRNA Vaccine: Design, Immunogenicity and Protection Efficacy

Novel Cis-Splicing System-Driven Efficient Circular RNA Production Empowers Next-Generation RNA Vaccine Development

A Novel mRNA-Based Therapeutic Vaccine Targeting HPV16/18 Oncoproteins: Preclinical Efficacy in Tumor Regression and Immune Activation

A Robust Self-amplifying RNA Platform for Prophylactic Vaccines

ABOF-1913, a Novel Ionizable Lipid for Enhanced Delivery and Efficacy of mRNA Vaccines

Immunogenicity, Efficacy and Long-term Stability of a Lyophilized mRNA Vaccine for Rabies

For more information about the conference, please visit the official website:

https://sites.google.com/sheffield.ac.uk/ukseavaxhub2025/home

About UK-SEA Vax Hub

UK-SEA Vax Hub (UK-Southeast Asia Vaccine Manufacturing and Research Center) is led by the University of Sheffield in the UK, in collaboration with the University of Cambridge, the University of York, the University of Kent, and several universities and institutions in Southeast Asia (such as Chulalongkorn University). It is an international collaborative platform dedicated to promoting equitable access to vaccines and enhancing the ability of low- and middle-income countries to respond to public health crises.

Supported by the UK Department of Health and Social Care (DHSC) and the Engineering and Physical Sciences Research Council (EPSRC), as part of the UK Vaccine Network (UKVN), the platform focuses on the development of protein subunit vaccines, mRNA vaccines, and viral vector vaccines. It aims to build a sustainable vaccine manufacturing system in Southeast Asia to address current and future epidemic challenges.